R&D expense · 2011–2025
TG Therapeutics R&D expense
$160M+69.9% · FY2025
TG Therapeutics (TGTX) reported $160M in R&D expense for fiscal 2025, +69.9% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $160M | +69.9% | Open → |
| FY20242024-12-31 | $94.3M | +23.8% | Open → |
| FY20232023-12-31 | $76.2M | −39.2% | Open → |
| FY20222022-12-31 | $125M | −43.7% | Open → |
| FY20212021-12-31 | $223M | +34.2% | Open → |
| FY20202020-12-31 | $166M | +7.6% | Open → |
| FY20192019-12-31 | $154M | −3.3% | Open → |
| FY20182018-12-31 | $159M | +55.5% | Open → |
| FY20172017-12-31 | $103M | +48.1% | Open → |
| FY20162016-12-31 | $69.2M | +45.1% | Open → |
| FY20152015-12-31 | $47.7M | +19.0% | Open → |
| FY20142014-12-31 | $40.1M | +193.4% | Open → |
| FY20132013-12-31 | $13.7M | −35.0% | Open → |
| FY20122012-12-31 | $21.0M | +6,325.0% | Open → |
| FY20112011-12-31 | $327,283 | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +55.6%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=TG Therapeutics R&D expense |url=https://companiesranked.com/en/company/tg-therapeutics/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). TG Therapeutics R&D expense. CompaniesRanked. https://companiesranked.com/en/company/tg-therapeutics/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-tg-therapeutics-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{TG Therapeutics R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/tg-therapeutics/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001437749-26-006133 · February 27, 2026
{{cite web |title=TG Therapeutics R&D expense — 10-K (0001437749-26-006133) |url=https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/tgtx20251231_10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.